Procurement Summary
Country: Brazil
Summary: the Present Process Aims to Acquire Cyclophosphamide Drugs 1 G Injectable Extemporaneous Dust, Vismodegib 150 Mg, Semaglutado 2.4 Mg, Dupilumab 300 Mg, Semaglutado 1.34 Mg/Ml, Dupi ...
Deadline: 01 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125313397
Document Ref. No.: 90245/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The present process aims to acquire cyclophosphamide drugs 1 g Injectable extemporaneous dust, vismodegib 150 mg, semaglutado 2.4 mg, dupilumab 300 mg, semagluctitated 1.34 mg/ml, dupilumab 200 mg, nintedanib 150 mg, human immunoglobulin 5 g, plerixafor 20 mg/ml - 150 mg, Bretantuximab Vedotine 50 mg and Sorafenib 200 mg, according to medical requests attached to the case file, aiming at compliance with court orders.
00733062000102-1-000309/2025
Buying Unit: 927502 - Rondonia State Health Fund
End of receipt of proposals: 01/09/2025 08:59 (Brasilia time)
of Proposals: 08/27/2025 15:12 (Brasilia time)
Documents
Tender Notice